Literature DB >> 8024848

Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides.

A M Bollen1, D R Eyre.   

Abstract

When bone is resorbed, cross-linking amino acids from collagen type I (pyridinolines) are excreted in the urine as small peptides. The purpose of this cross-sectional study was to measure the urinary excretion of type I collagen bone degradation products in children and to correlate the results with growth velocity on a population basis. Spot urines from 1076 children and 24 adults were analyzed. The concentrations of cross-linked N-telopeptides of collage type I were measured using a new monoclonal antibody-based microtiter-plate assay, and normalized to creatinine. Age-related changes in cross-link excretion mirrored published standard growth velocity rates for males and females. The correlation coefficient between growth rates and cross-link excretion was 0.91. These results encourage more definitive longitudinal studies where growth rates and collagen cross-link excretion are correlated on an individual-patient basis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024848     DOI: 10.1016/8756-3282(94)90888-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

1.  A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.

Authors:  C Heuck; L Heickendorff; O D Wolthers
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

2.  The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.

Authors:  Frank Rauch; Rose Travers; Horacio Plotkin; Francis H Glorieux
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

3.  A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls.

Authors:  Thomas O Carpenter; Maria C DeLucia; Jane Hongyuan Zhang; Gina Bejnerowicz; Lisa Tartamella; James Dziura; Kitt Falk Petersen; Douglas Befroy; Dorothy Cohen
Journal:  J Clin Endocrinol Metab       Date:  2006-10-03       Impact factor: 5.958

4.  Celiac autoimmunity in children with type 1 diabetes: a two-year follow-up.

Authors:  Jill H Simmons; Georgeanna J Klingensmith; Kim McFann; Marian Rewers; Lisa M Ide; Iman Taki; Edwin Liu; Edward J Hoffenberg
Journal:  J Pediatr       Date:  2011-02       Impact factor: 4.406

5.  Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI.

Authors:  B Steinmann; D R Eyre; P Shao
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

6.  Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds.

Authors:  S M Husain; Z Mughal; G Williams; K Ward; C S Smith; J Dutton; W D Fraser
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

7.  Impaired pyridinoline cross-link formation in patients with osteogenesis imperfecta.

Authors:  Kosei Hasegawa; Kyoko Kataoka; Masaru Inoue; Yoshiki Seino; Tsuneo Morishima; Hiroyuki Tanaka
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

8.  Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis.

Authors:  Eduardo Lopez-Granados; Stephane T Temmerman; Lynne Wu; James C Reynolds; Dean Follmann; Shuying Liu; David L Nelson; Frank Rauch; Ashish Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-09       Impact factor: 11.205

9.  Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease.

Authors:  L M Ward; F Rauch; M A Matzinger; E I Benchimol; M Boland; D R Mack
Journal:  Osteoporos Int       Date:  2009-06-06       Impact factor: 4.507

10.  Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO).

Authors:  Paivi Mh Miettunen; Xingchang Wei; Deepak Kaura; Walid Abou Reslan; Alberto Nettel Aguirre; James D Kellner
Journal:  Pediatr Rheumatol Online J       Date:  2009-01-12       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.